Cleveland.com: Biotech startup Lamassu, Cleveland Clinic aim to treat rare cancers with just three pills a month

11/05/2024

CLEVELAND, Ohio — A biotech startup from North Carolina thinks Cleveland is where it will develop how to treat rare cancers with just three pills a month.

If effective, Lamassu Biotech’s innovative gene therapy could eliminate the need for surgery or chemotherapy for some types of hard-to-treat cancer, said CEO Dr. Gabi Hanna.

CLICK HERE to read the full story from Cleveland.com.

READ MORE

10/06/2025

Drug Discovery Online: Answering The Call To Develop Novel Drugs For Rare DiseasesDrug Discovery Online:

Faced with a serious diagnosis or an unexpected hospitalization, patients and their families are often left feeling like they’ve been hit with a gut punch. This insecurity is compounded when the diagnosis is some type of rare condition, such as...

READ THE ARTICLE
06/26/2025

Crain’s Cleveland Business: The U.S. Is Losing Its Biotech Edge

Biotech is one of America’s most critical innovation sectors, but it is facing serious headwinds. Since COVID-19, the industry has been hammered by falling investor confidence, sluggish IPO markets, and rising international competition.  If we do not act to strengthen...

READ THE ARTICLE
06/06/2025

Crain’s Cleveland Business: Cleveland biotech company secures $2.7M in NIH funding

Lamassu Biotech, a company with its “second headquarters” in Cleveland, has received a $2.7 million grant from the National Institutes of Health (NIH). The funds will help support the development of a novel treatment protocol for acute pancreatitis in canines....

READ THE ARTICLE